121 related articles for article (PubMed ID: 9586697)
1. A tetrazolium-based colorimetric assay for titration of neutralizing antibodies against vaccinia virus.
Ifrah M; Stienlauf S; Shoresh M; Katz E
Viral Immunol; 1998; 11(1):49-54. PubMed ID: 9586697
[TBL] [Abstract][Full Text] [Related]
2. Growth and infectivity assays of the Israeli vaccine strain of fowl poxvirus in chicken embryo fibroblasts.
Hashavya S; Barchichat S; Katz E
Avian Dis; 2002; 46(1):95-101. PubMed ID: 11922352
[TBL] [Abstract][Full Text] [Related]
3. Accuracy and repeatability of a micro plaque reduction neutralization test for vaccinia antibodies.
Borges MB; Kato SE; Damaso CR; Moussatché N; da Silva Freire M; Lambert Passos SR; do Nascimento JP
Biologicals; 2008 Mar; 36(2):105-10. PubMed ID: 17892944
[TBL] [Abstract][Full Text] [Related]
4. Standardization of a neutralizing anti-vaccinia antibodies titration method: an essential step for titration of vaccinia immunoglobulins and smallpox vaccines evaluation.
Leparc-Goffart I; Poirier B; Garin D; Tissier MH; Fuchs F; Crance JM
J Clin Virol; 2005 Jan; 32(1):47-52. PubMed ID: 15572006
[TBL] [Abstract][Full Text] [Related]
5. Improved assay to detect neutralizing antibody following vaccination with diluted or undiluted vaccinia (Dryvax) vaccine.
Newman FK; Frey SE; Blevins TP; Mandava M; Bonifacio A; Yan L; Belshe RB
J Clin Microbiol; 2003 Jul; 41(7):3154-7. PubMed ID: 12843056
[TBL] [Abstract][Full Text] [Related]
6. Development of a tissue-culture-based enzyme-immunoassay method for the quantitation of anti-vaccinia-neutralizing antibodies in human sera.
Eyal O; Olshevsky U; Lustig S; Paran N; Halevy M; Schneider P; Zomber G; Fuchs P
J Virol Methods; 2005 Dec; 130(1-2):15-21. PubMed ID: 16024096
[TBL] [Abstract][Full Text] [Related]
7. A novel high-throughput vaccinia virus neutralization assay and preexisting immunity in populations from different geographic regions in China.
Liu Q; Huang W; Nie J; Zhu R; Gao D; Song A; Meng S; Xu X; Wang Y
PLoS One; 2012; 7(3):e33392. PubMed ID: 22438922
[TBL] [Abstract][Full Text] [Related]
8. Vaccinia virus H3L envelope protein is a major target of neutralizing antibodies in humans and elicits protection against lethal challenge in mice.
Davies DH; McCausland MM; Valdez C; Huynh D; Hernandez JE; Mu Y; Hirst S; Villarreal L; Felgner PL; Crotty S
J Virol; 2005 Sep; 79(18):11724-33. PubMed ID: 16140750
[TBL] [Abstract][Full Text] [Related]
9. Neutralization assay using a modified vaccinia virus Ankara vector expressing the green fluorescent protein is a high-throughput method to monitor the humoral immune response against vaccinia virus.
Cosma A; Bühler S; Nagaraj R; Staib C; Hammarin AL; Wahren B; Goebel FD; Erfle V; Sutter G
Clin Diagn Lab Immunol; 2004 Mar; 11(2):406-10. PubMed ID: 15013995
[TBL] [Abstract][Full Text] [Related]
10. A novel, colorimetric neutralization assay for measuring antibodies to influenza viruses.
Lehtoranta L; Villberg A; Santanen R; Ziegler T
J Virol Methods; 2009 Aug; 159(2):271-6. PubMed ID: 19406159
[TBL] [Abstract][Full Text] [Related]
11. Activity of vaccinia virus-neutralizing antibody in the sera of smallpox vaccinees.
Viner KM; Isaacs SN
Microbes Infect; 2005 Apr; 7(4):579-83. PubMed ID: 15848274
[TBL] [Abstract][Full Text] [Related]
12. Development of a novel vaccinia-neutralization assay based on reporter-gene expression.
Manischewitz J; King LR; Bleckwenn NA; Shiloach J; Taffs R; Merchlinsky M; Eller N; Mikolajczyk MG; Clanton DJ; Monath T; Weltzin RA; Scott DE; Golding H
J Infect Dis; 2003 Aug; 188(3):440-8. PubMed ID: 12870127
[TBL] [Abstract][Full Text] [Related]
13. Establishment of a national network of validated and qualified laboratories for neutralizing anti-vaccinia antibodies titration.
Poirier B; Leparc-Goffart I; Crance JM; Fleury H; Garin D; Gut JP; Tissier MH; Fuchs F
Biologicals; 2005 Dec; 33(4):277-82. PubMed ID: 16181788
[TBL] [Abstract][Full Text] [Related]
14. A rapid, high-throughput vaccinia virus neutralization assay for testing smallpox vaccine efficacy based on detection of green fluorescent protein.
Johnson MC; Damon IK; Karem KL
J Virol Methods; 2008 Jun; 150(1-2):14-20. PubMed ID: 18387679
[TBL] [Abstract][Full Text] [Related]
15. Smallpox vaccine, ACAM2000: Sites and duration of viral shedding and effect of povidone iodine on scarification site shedding and immune response.
Pittman PR; Garman PM; Kim SH; Schmader TJ; Nieding WJ; Pike JG; Knight R; Johnston SC; Huggins JW; Kortepeter MG; Korman L; Ranadive M; Quinn X; Meyers MS
Vaccine; 2015 Jun; 33(26):2990-6. PubMed ID: 25930115
[TBL] [Abstract][Full Text] [Related]
16. Monitoring of human immunological responses to vaccinia virus.
Harrop R; Ryan MG; Golding H; Redchenko I; Carroll MW
Methods Mol Biol; 2004; 269():243-66. PubMed ID: 15114020
[TBL] [Abstract][Full Text] [Related]
17. A novel, spectrophotometric microneutralization assay for respiratory syncytial virus.
Rubino KL; Nicholas JA
J Virol Methods; 1992 Sep; 39(1-2):55-67. PubMed ID: 1430065
[TBL] [Abstract][Full Text] [Related]
18. Adaptation of the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) assay for the determination of virus-neutralizing antibodies using the virus-neutralization assay.
Haddad EE; Whitfill CE; Ricks CA; Fredericksen T; Rowe D; Owen L; Baldridge A; Murray L; Thoma JA
Avian Dis; 1994; 38(4):755-61. PubMed ID: 7702508
[TBL] [Abstract][Full Text] [Related]
19. Neutralizing and protective antibodies directed against vaccinia virus envelope antigens.
Galmiche MC; Goenaga J; Wittek R; Rindisbacher L
Virology; 1999 Feb; 254(1):71-80. PubMed ID: 9927575
[TBL] [Abstract][Full Text] [Related]
20. Vaccination of BALB/c mice with Escherichia coli-expressed vaccinia virus proteins A27L, B5R, and D8L protects mice from lethal vaccinia virus challenge.
Berhanu A; Wilson RL; Kirkwood-Watts DL; King DS; Warren TK; Lund SA; Brown LL; Krupkin AK; Vandermay E; Weimers W; Honeychurch KM; Grosenbach DW; Jones KF; Hruby DE
J Virol; 2008 Apr; 82(7):3517-29. PubMed ID: 18199639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
